Targeting the Programmed Cell Death-1 Pathway in Genitourinary Tumors: Current Progress and Future Perspectives-Reference-Cited by-同舟云学术

Targeting the Programmed Cell Death-1 Pathway in Genitourinary Tumors: Current Progress and Future Perspectives

Published:2017-10-16 Issue:8 Volume:18 Page:
ISSN:1389-2002
Container-title:Current Drug Metabolism
language:en
Short-container-title:CDM

Author:

Mann Steven A.¹,Lopez-Beltran Antonio²,Massari Francesco³,Pili Roberto⁴,Fiorentino Michelangelo⁵,Koch Michael O.⁶,Kaimakliotis Hristos Z.⁶,Wang Lisha⁷,Scarpelli Marina⁸,Ciccarese Chiara⁹,Moch Holger¹⁰,Montironi Rodolfo⁸,Cheng Liang¹¹

Affiliation:

1. Departments of Pathology, Indiana University School of Medicine, Indianapolis, United States

2. Unit of Anatomical Pathology, Faculty of Cordoba University, Cordoba, Spain and Champalimaud Clinical Center, Lisbon, Portugal

3. Division of Oncology, S.Orsola-Malpighi Hospital, Bologna, Italy

4. Departments of Internal Medicine Indiana University School of Medicine, Indianapolis, United States

5. Pathology Service, Addarii Institute of Oncology, S. Orsola-Malpighi Hospital, Bologna, Italy

6. Departments of Urology, Indiana University School of Medicine, Indianapolis, United States

7. Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, Michigan, United States

8. Institute of Pathological Anatomy and Histopathology, School of Medicine, Polytechnic University of the Marche Region (Ancona), United Hospitals, Ancona, Italy

9. Medical Oncology, Azienda Ospedaliera Universitaria Integrata, University of Verona, Verona, Italy

10. Institute of Surgical Pathology, University of Zurich, Zurich, Switzerland

11. Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, 350 West 11th Street, IUHPL Room 4010, Indianapolis, IN 46202, United States

Publisher

Bentham Science Publishers Ltd.

Subject

Clinical Biochemistry,Pharmacology

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bridging radiomics to tumor immune microenvironment assessment in clear cell renal cell carcinoma;18th International Symposium on Medical Information Processing and Analysis;2023-03-06

2. Precision Medicine: An Optimal Approach to Patient Care in Renal Cell Carcinoma;Frontiers in Medicine;2022-06-14

3. Comprehensive analysis of the importance of PLAUR in the progression and immune microenvironment of renal clear cell carcinoma;PLOS ONE;2022-06-08

4. Integrated analysis of immune-related gene subtype and immune index for immunotherapy in clear cell renal cell carcinoma;Pathology - Research and Practice;2021-09

5. Pembrolizumab for advanced penile cancer: a case series from a phase II basket trial;Investigational New Drugs;2021-03-26